We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Nymox Pharmaceutical Corp | NASDAQ:NYMX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.20 | 0.2003 | 0.2169 | 0 | 01:00:00 |
From May 2019 to May 2024
What You May Do
If you purchased shares of Nymox and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 26, 2015.
About the Lawsuit
Nymox and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On November 2, 2014, Nymox disclosed that the Company's two Phase 3 clinical trials for its proprietary drug NX-1207 for the treatment of benign prostatic hyperplastic (BPH) had to be halted because the drug failed to meet its primary endpoints for efficacy. The following day, Nymox disclosed to the market for the first time, among other things, the difficulties faced in enrolling men for the trials, and the subjective nature of the measurement of the drug's success.
On this news, the price of Nymox's stock plummeted by over 80%.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.
Hot Features
Premium
CONTACT: Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447
1 Year Nymox Pharmaceutical Chart |
1 Month Nymox Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
